NR 507 Advanced Pathophysiology Midterm
Exam Official Practice Exam Actual Exam
2026/2027 with Detailed Rationales |
Complete Exam-Style Questions | Pass
Guaranteed – A+ Graded
═════════════════════════════════════
SECTION 1: CELLULAR BIOLOGY & GENETICS Q1 – Q10
══════════════════════════════════════
Question 1 of 50
A 58-year-old male with a 40 pack-year smoking history presents with hemoptysis and a 3 cm
right upper lobe mass. Biopsy reveals small cell lung carcinoma. Molecular analysis shows a
missense mutation in the TP53 gene resulting in a nonfunctional protein. The
pathophysiologist explains that this mutation directly disrupts which cellular checkpoint
mechanism?
A. Activation of cyclin D1 to drive progression from G1 to S phase
B. Induction of cell cycle arrest at the G1/S boundary in response to DNA damage ✓
CORRECT
C. Phosphorylation of histone proteins to permit chromatin condensation during mitosis
D. Recruitment of DNA ligase IV to repair double-strand breaks via nonhomologous end
joining
Correct Answer: B
Rationale: Wild-type p53 functions as the guardian of the genome by sensing DNA damage
and triggering G1/S cell cycle arrest to allow repair or initiate apoptosis; loss of this
checkpoint permits uncontrolled proliferation and accumulation of additional mutations.
Activation of cyclin D1 describes an oncogenic mechanism driven by growth factor signaling,
not a tumor suppressor checkpoint function. In clinical practice, TP53 mutations are among
the most common driver alterations in solid tumors and directly correlate with genomic
instability and therapeutic resistance.
Question 2 of 50
A 72-year-old female with end-stage ovarian cancer develops tumor lysis syndrome after
initial chemotherapy. Her serum potassium is 6.2 mEq/L, phosphorus is 5.8 mg/dL, and she
,becomes oliguric. The intensive care team observes that massive cell death in this setting
releases intracellular contents into the extracellular space. Which mechanism best describes
the primary mode of cell death occurring in malignant cells exposed to cytotoxic
chemotherapy?
A. Programmed cell death characterized by cytochrome c release from mitochondria and
caspase activation
B. Oncosis driven by rapid ATP depletion and loss of plasma membrane integrity ✓ CORRECT
C. Autophagic cell death resulting from excessive lysosomal degradation of organelles
D. Pyroptosis mediated by inflammasome activation and gasdermin D pore formation
Correct Answer: B
Rationale: Cytotoxic chemotherapy primarily induces oncotic cell death through direct DNA
damage and metabolic disruption, causing rapid ATP depletion, cell swelling, and plasma
membrane rupture that releases intracellular potassium, phosphorus, and nucleic acids into
the circulation. While apoptosis does occur, the massive electrolyte shifts and hyperuricemia
seen in tumor lysis syndrome are hallmarks of oncotic membrane failure rather than the
contained, phagocytosed remnants of apoptotic cells. Clinicians must recognize that tumor
lysis syndrome represents a medical emergency requiring aggressive hydration and
rasburicase to prevent acute kidney injury from uric acid crystallization.
Question 3 of 50
A 45-year-old Ashkenazi Jewish woman with a strong family history of breast and ovarian
cancer undergoes genetic testing. Sequencing reveals a pathogenic BRCA1 frameshift
mutation. Her oncologist explains that this mutation elevates her lifetime cancer risk
because BRCA1 normally participates in which DNA repair pathway?
A. Homologous recombination repair of double-strand breaks ✓ CORRECT
B. Base excision repair of oxidative DNA damage
C. Nucleotide excision repair of UV-induced thymine dimers
D. Mismatch repair of replication errors
Correct Answer: A
Rationale: BRCA1 is a tumor suppressor that facilitates homologous recombination by
promoting RAD51 filament assembly at DNA double-strand breaks; loss of this function
causes genomic instability and predisposition to breast, ovarian, and prostate cancers. Base
excision repair depends on enzymes such as OGG1 and APE1 to correct oxidative base
damage, a pathway unrelated to BRCA1 function. Patients with BRCA1 mutations benefit from
PARP inhibitor therapy because synthetic lethality exploits the inability to repair DNA via
homologous recombination.
Question 4 of 50
, A 34-year-old male with chronic hepatitis C infection develops hepatocellular carcinoma.
Histology reveals abundant Mallory-Denk bodies and ballooning degeneration. The
pathophysiologist identifies this as an example of cellular adaptation in which the
hepatocytes accumulate misfolded proteins because the endoplasmic reticulum stress
response has been overwhelmed. Which cellular process is primarily impaired?
A. Proteasomal degradation of ubiquitinated proteins
B. Chaperone-mediated autophagy of cytosolic proteins
C. Unfolded protein response and ER-associated degradation ✓ CORRECT
D. Lysosomal acid hydrolase trafficking to the Golgi apparatus
Correct Answer: C
Rationale: Chronic oxidative and inflammatory stress in hepatitis C overwhelms the unfolded
protein response, causing accumulation of misfolded proteins in the endoplasmic reticulum
that aggregate into Mallory-Denk bodies and trigger hepatocyte injury. Impaired proteasomal
degradation typically occurs in neurodegenerative diseases such as Parkinson disease, not in
this hepatic context. Recognizing ER stress as a driver of hepatocarcinogenesis helps explain
why antiviral therapy reduces but does not eliminate cancer risk in patients with advanced
fibrosis.
Question 5 of 50
A 6-year-old child presents with bilateral retinoblastomas. Genetic testing confirms a
heterozygous germline mutation in the RB1 tumor suppressor gene. During a family
counseling session, the genetic counselor explains that the child inherited one mutated allele
and the second wild-type allele was subsequently lost in the retinal cell. Which molecular
mechanism best explains the development of this malignancy?
A. Activation of a proto-oncogene through chromosomal translocation
B. Loss of heterozygosity at a tumor suppressor locus ✓ CORRECT
C. Epigenetic silencing via CpG island hypermethylation of an oncogene promoter
D. Microsatellite instability from defective mismatch repair
Correct Answer: B
Rationale: Retinoblastoma follows the two-hit hypothesis: a child inherits one defective RB1
allele, and somatic loss of the remaining wild-type allele through mutation, deletion, or
mitotic recombination eliminates cell cycle control at the G1/S restriction point.
Chromosomal translocation activating proto-oncogenes is characteristic of leukemias and
sarcomas, not retinoblastoma. Understanding this mechanism is essential for genetic
counseling because carriers of germline RB1 mutations have elevated lifetime risks of
osteosarcoma and melanoma.
Question 6 of 50
Exam Official Practice Exam Actual Exam
2026/2027 with Detailed Rationales |
Complete Exam-Style Questions | Pass
Guaranteed – A+ Graded
═════════════════════════════════════
SECTION 1: CELLULAR BIOLOGY & GENETICS Q1 – Q10
══════════════════════════════════════
Question 1 of 50
A 58-year-old male with a 40 pack-year smoking history presents with hemoptysis and a 3 cm
right upper lobe mass. Biopsy reveals small cell lung carcinoma. Molecular analysis shows a
missense mutation in the TP53 gene resulting in a nonfunctional protein. The
pathophysiologist explains that this mutation directly disrupts which cellular checkpoint
mechanism?
A. Activation of cyclin D1 to drive progression from G1 to S phase
B. Induction of cell cycle arrest at the G1/S boundary in response to DNA damage ✓
CORRECT
C. Phosphorylation of histone proteins to permit chromatin condensation during mitosis
D. Recruitment of DNA ligase IV to repair double-strand breaks via nonhomologous end
joining
Correct Answer: B
Rationale: Wild-type p53 functions as the guardian of the genome by sensing DNA damage
and triggering G1/S cell cycle arrest to allow repair or initiate apoptosis; loss of this
checkpoint permits uncontrolled proliferation and accumulation of additional mutations.
Activation of cyclin D1 describes an oncogenic mechanism driven by growth factor signaling,
not a tumor suppressor checkpoint function. In clinical practice, TP53 mutations are among
the most common driver alterations in solid tumors and directly correlate with genomic
instability and therapeutic resistance.
Question 2 of 50
A 72-year-old female with end-stage ovarian cancer develops tumor lysis syndrome after
initial chemotherapy. Her serum potassium is 6.2 mEq/L, phosphorus is 5.8 mg/dL, and she
,becomes oliguric. The intensive care team observes that massive cell death in this setting
releases intracellular contents into the extracellular space. Which mechanism best describes
the primary mode of cell death occurring in malignant cells exposed to cytotoxic
chemotherapy?
A. Programmed cell death characterized by cytochrome c release from mitochondria and
caspase activation
B. Oncosis driven by rapid ATP depletion and loss of plasma membrane integrity ✓ CORRECT
C. Autophagic cell death resulting from excessive lysosomal degradation of organelles
D. Pyroptosis mediated by inflammasome activation and gasdermin D pore formation
Correct Answer: B
Rationale: Cytotoxic chemotherapy primarily induces oncotic cell death through direct DNA
damage and metabolic disruption, causing rapid ATP depletion, cell swelling, and plasma
membrane rupture that releases intracellular potassium, phosphorus, and nucleic acids into
the circulation. While apoptosis does occur, the massive electrolyte shifts and hyperuricemia
seen in tumor lysis syndrome are hallmarks of oncotic membrane failure rather than the
contained, phagocytosed remnants of apoptotic cells. Clinicians must recognize that tumor
lysis syndrome represents a medical emergency requiring aggressive hydration and
rasburicase to prevent acute kidney injury from uric acid crystallization.
Question 3 of 50
A 45-year-old Ashkenazi Jewish woman with a strong family history of breast and ovarian
cancer undergoes genetic testing. Sequencing reveals a pathogenic BRCA1 frameshift
mutation. Her oncologist explains that this mutation elevates her lifetime cancer risk
because BRCA1 normally participates in which DNA repair pathway?
A. Homologous recombination repair of double-strand breaks ✓ CORRECT
B. Base excision repair of oxidative DNA damage
C. Nucleotide excision repair of UV-induced thymine dimers
D. Mismatch repair of replication errors
Correct Answer: A
Rationale: BRCA1 is a tumor suppressor that facilitates homologous recombination by
promoting RAD51 filament assembly at DNA double-strand breaks; loss of this function
causes genomic instability and predisposition to breast, ovarian, and prostate cancers. Base
excision repair depends on enzymes such as OGG1 and APE1 to correct oxidative base
damage, a pathway unrelated to BRCA1 function. Patients with BRCA1 mutations benefit from
PARP inhibitor therapy because synthetic lethality exploits the inability to repair DNA via
homologous recombination.
Question 4 of 50
, A 34-year-old male with chronic hepatitis C infection develops hepatocellular carcinoma.
Histology reveals abundant Mallory-Denk bodies and ballooning degeneration. The
pathophysiologist identifies this as an example of cellular adaptation in which the
hepatocytes accumulate misfolded proteins because the endoplasmic reticulum stress
response has been overwhelmed. Which cellular process is primarily impaired?
A. Proteasomal degradation of ubiquitinated proteins
B. Chaperone-mediated autophagy of cytosolic proteins
C. Unfolded protein response and ER-associated degradation ✓ CORRECT
D. Lysosomal acid hydrolase trafficking to the Golgi apparatus
Correct Answer: C
Rationale: Chronic oxidative and inflammatory stress in hepatitis C overwhelms the unfolded
protein response, causing accumulation of misfolded proteins in the endoplasmic reticulum
that aggregate into Mallory-Denk bodies and trigger hepatocyte injury. Impaired proteasomal
degradation typically occurs in neurodegenerative diseases such as Parkinson disease, not in
this hepatic context. Recognizing ER stress as a driver of hepatocarcinogenesis helps explain
why antiviral therapy reduces but does not eliminate cancer risk in patients with advanced
fibrosis.
Question 5 of 50
A 6-year-old child presents with bilateral retinoblastomas. Genetic testing confirms a
heterozygous germline mutation in the RB1 tumor suppressor gene. During a family
counseling session, the genetic counselor explains that the child inherited one mutated allele
and the second wild-type allele was subsequently lost in the retinal cell. Which molecular
mechanism best explains the development of this malignancy?
A. Activation of a proto-oncogene through chromosomal translocation
B. Loss of heterozygosity at a tumor suppressor locus ✓ CORRECT
C. Epigenetic silencing via CpG island hypermethylation of an oncogene promoter
D. Microsatellite instability from defective mismatch repair
Correct Answer: B
Rationale: Retinoblastoma follows the two-hit hypothesis: a child inherits one defective RB1
allele, and somatic loss of the remaining wild-type allele through mutation, deletion, or
mitotic recombination eliminates cell cycle control at the G1/S restriction point.
Chromosomal translocation activating proto-oncogenes is characteristic of leukemias and
sarcomas, not retinoblastoma. Understanding this mechanism is essential for genetic
counseling because carriers of germline RB1 mutations have elevated lifetime risks of
osteosarcoma and melanoma.
Question 6 of 50
